Delivery Order SPE2DB22D1017-SPE2DB24FF0EV
Award Date 12/22/23
Potential Completion Date 12/26/23
Potential Value $1.4K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,564,084,872 units of Fluticasone Prop HFA 220 MCG 12GM. The contract, valued at $30,713.34, has an ultimate completion date of March 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 and awarded...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product, with a potential value of $2,011.44. The delivery order has a completion date of January 5, 2024. No set-aside designation was used for this award. Amerisourcebergen...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,923.12 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563652915 - FLUTICASONE PROP HFA 220 MCG 12GM. This contract has a completion date of February 14, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this delivery order, which is not associated with any set-aside program. In addition, Amerisourcebergen Drug...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $1,812.93, is for the provision of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product, in support of military treatment programs and facilities. The delivery order has an ultimate completion date of...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Fluticasone Prop HFA 220 MCG 12GM pharmaceutical products. The contract has a potential value of $2,022.04 and a completion date of January 5, 2024. Amerisourcebergen Drug Corp has a long history of providing pharmaceutical and medical supplies to support various Department of Defense (DoD) programs...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a subsidiary of parent company Cencora, Inc. The $1,748.61 contract is for the delivery of Fluticasone Prop HFA 220 MCG 12GM, a prescription pharmaceutical product, to support military medical treatment programs. The order has a completion date of March 5, 2024 and was awarded on March 4, 2024. No set-aside was used for this award. AmerisourceBergen Drug Corporation...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $3,303.06 order is for the supply of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. The delivery order has a completion date of December 20, 2023. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to provide pharmaceuticals, medical supplies, and related...
- The Defense Logistics Agency (DLA) awarded a $4,973.03 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Fluticasone Prop HFA 110 MCG 12GM. The contract is for the delivery of pharmaceutical products and has a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This order is part of a larger indefinite delivery contract (IDC) awarded by...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order, valued at $4,104.60, is for the delivery of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product, with a completion date of January 9, 2024. The contract has no set-aside designation. Amerisourcebergen Drug Corp has previously received...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a pharmaceutical product - Fluticasone Prop HFA 110 MCG 12GM. The contract has a potential value of $3,937.85 and a completion date of February 20, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceuticals and medical supplies to U.S. government agencies, notably the Department of...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF0EVDelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Fluticasone Prop HFA 220 MCG 12GM. The order has a potential value of $1,428.29 and a completion date of December 26, 2023. Amerisourcebergen Drug Corp is a prime contractor that has previously received numerous federal contracts from DLA to provide pharmaceuticals, medical supplies, and related distribution services in support of military treatment programs and facilities. This delivery order does not have a set-aside designation. Amerisourcebergen Drug Corp's parent company is Cencora, Inc., which does business as Amerisourcebergen.
Generated 3/22/24, 10:43 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 12/22/23 |